Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer

Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer

Background and ObjectiveTo assess the efficacy of a Risk-Adapted Ablative Radiotherapy (RAdAR) approach, after intensive induction chemotherapy, in patients with locally advanced pancreatic cancer (LAPC).Material and MethodsPatients with LAPC who received RAdAR following induction chemotherapy from...

Full description

Bibliographic Details
Main Authors: Gabriella Rossi, Nicola Simoni, Salvatore Paiella, Roberto Rossi, Martina Venezia, Renato Micera, Giuseppe Malleo, Roberto Salvia, Tommaso Giuliani, Anthony Di Gioia, Alessandra Auriemma, Michele Milella, Stefania Guariglia, Carlo Cavedon, Claudio Bassi, Renzo Mazzarotto
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Oncology
Subjects:
pancreatic cancer
locally advanced
SBRT (stereotactic body radiation therapy)
hypofractionated ablative radiation
SAbR
ablative dose
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.662205/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.662205/full

Similar Items